January 25, 2018

FDA: AuroMedics recalls one lot of Levofloxacin

By: Judy Mathias

Editor’s Note

The Food & Drug Administration (FDA) on January 18 announced the recall by AuroMedics (East Windsor, New Jersey) of one lot of Levofloxacin in 5% Dextrose Injection 250 mg/50 mL in a single-use flexible container (NDC 55150-243-46, Lot CLF160003, Expiry date May 2018).

The product has been found to contain visible particulate matter tentatively identified as mold. AuroMedics shipped the lot to customers nationwide from September 19 through October 31, 2017.


Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

Live chat by BoldChat